These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5108201)

  • 1. [Antihypertensive activities of combinations os musculotropic peripheral vasodilators with reserpine].
    Stoepel K
    Arzneimittelforschung; 1971 Jan; 21(1):54-7. PubMed ID: 5108201
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies with a new antihypertensive agent, Bendigon].
    Wardemann H
    Med Welt; 1970 Sep; 37():1617-20. PubMed ID: 5526791
    [No Abstract]   [Full Text] [Related]  

  • 3. [The action of the antihypertensive agent Bendigon on serum lipids (author's transl)].
    Studlar M
    Med Klin; 1975 Jan; 70(3-2):102-5. PubMed ID: 805354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [To the mechanism of hypotensive effect of ethyl ether of nicotinic acid (Nicethane)].
    Sidoruk GIa
    Farmakol Toksikol; 1966; 29(2):135-6. PubMed ID: 6000335
    [No Abstract]   [Full Text] [Related]  

  • 5. [Critical review on vasodilators].
    Goto F; Akiyama M
    Jibiinkoka; 1969 Oct; 40(10):785-96. PubMed ID: 4236877
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of reserpine pretreatment on in vivo femoral arterial responses to vasodilator agents.
    Cauvin CA; Devia CJ; Kirkendol PL
    J Pharmacol Exp Ther; 1981 Mar; 216(3):447-52. PubMed ID: 6782236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive combination-therapy with inositol nicotinate in essential hypertension].
    Krämer KD; Ghabussi P; Hochrein H
    Med Welt; 1977 Jul; 28(27):1198-1201. PubMed ID: 329049
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on some pharmacologic properties of a new ester of the nicotinic acid: mesoinositol-pentanicotinate.
    Linari G
    Arzneimittelforschung; 1972 Aug; 22(8):1419-21. PubMed ID: 4678404
    [No Abstract]   [Full Text] [Related]  

  • 9. [Design and evaluation of a clinical study comparing combinations of antihypertensive agents].
    Scheiber V; Wohlzogen FX; Esch I
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):346-51. PubMed ID: 4996196
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of reserpine and dihydrazinophthalazine on cerebrospinal fluid and blood catecholamines in the hypertensive disease.
    Ciplea A; Bubuianu G
    Rev Roum Physiol; 1969; 6(4):267-74. PubMed ID: 4926779
    [No Abstract]   [Full Text] [Related]  

  • 11. General pharmacological actions of some synthetic tetrahydrocannabinol derivatives.
    Hardman HF; Domino EF; Seevers MH
    Pharmacol Rev; 1971 Dec; 23(4):295-315. PubMed ID: 5002533
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of preexperimental blood pressure level on hypotensive responses to vasodilator drugs.
    Serrano JS; Pelayo F; Tamargo JL; García De Jalón PD
    Arch Farmacol Toxicol; 1975 Aug; 1(2):91-8. PubMed ID: 1230033
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative determination of the efficacy of combinations of antihypertensive agents].
    Steopel K; Kaller H; Kroneberg G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):207-8. PubMed ID: 4239235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical tests with a new antihypertensive combination (Bendigon)].
    Hesseling W
    Med Welt; 1970 Sep; 37():1621-5. PubMed ID: 5526792
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ophthalmodynamometric and tonographic analysis of the influence of a vasodilator agent on intracranial blood circulation and intraocular pressure].
    Makabe R
    Klin Monbl Augenheilkd; 1971 Feb; 158(2):309. PubMed ID: 5555614
    [No Abstract]   [Full Text] [Related]  

  • 16. [Piperazine-derivatives. II. Effect of piperazine-derivatives].
    Lányi K; Erdélyi I; Institoris E; Tardos L; Szabó Z
    Arzneimittelforschung; 1968 Nov; 18(11):1431-5. PubMed ID: 5755908
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
    Nayler WG; Price JM; Swann JB; McInnes I; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intraoperative measurement of peripheral resistance in arterial circulatory disturbances and the effect of acetylcholine and nicotinic acid].
    Heinrich P; Förster HJ
    Z Exp Chir; 1971; 4(3):148-51. PubMed ID: 5162948
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicotinic acid esters as coronary vasodilators.
    Bariana DS; Savic M
    J Med Chem; 1971 Apr; 14(4):372-3. PubMed ID: 5553757
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative determination of the efficacy of antihypertensive agent combinations].
    Stoepel K; Kaller H; Kroneberg G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(2):189-96. PubMed ID: 4239710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.